Dr. Yuki Higashimoto | Healthcare Applications | Best Researcher Award

Dr. Yuki Higashimoto | Healthcare Applications | Best Researcher Award

Doctorate at Fujita Health University, Japan

Profiles

Orcid

Education

Dr. Yuki completed his primary education with 6 years in primary school, followed by 3 years in junior high school and 3 years in senior high school. He pursued his university education at Fujita Health University School of Health Sciences from 2003 to 2007. He continued his graduate studies at Fujita Health University Graduate School of Health Sciences, earning his Master’s degree from 2007 to 2009. He later obtained his Doctor of Philosophy in Medicine (PhD) in September 2018 from the Graduate School of Medicine, Fujita Health University.

Professional Experience

From 2009 to 2017, Dr. Yuki worked as a Medical Technologist in the Department of Clinical Laboratory at Fujita Health University Hospital, Toyoake, Aichi, Japan. He served as an Assistant Professor at the Faculty of Medical Technology, Fujita Health University, from 2017 to August 2021. Additionally, he continued as a Medical Technologist at Fujita Health University Hospital until 2022.

📚 Teaching and Academic Appointments

Since September 2021, Dr. Yuki has held the position of Senior Assistant Professor of Clinical Microbiology and Clinical Immunology at the Faculty of Medical Technology, Fujita Health University, Toyoake, Aichi, Japan.

🏆 Honors and Awards

In 2018, Dr. Yuki received the Young Scientist Incentive Award from The Japanese Society of Clinical Virology.

🔬 Professional Memberships

Dr. Yuki is an active member of several professional organizations, including The Japanese Society for Virology, The Japanese Society of Clinical Virology, The Japanese Society of Vaccinology, The Japanese Society for Clinical Microbiology, The Japan Association for Clinical Laboratory Science, and the Japanese Society of Food Science and Risk Analysis.

 Publications

Generation of Recombinant Authentic Live Attenuated Human Rotavirus Vaccine Strain RIX4414 (Rotarix<sup>®</sup>) from Cloned cDNAs Using Reverse Genetics
  • Authors: Saori Fukuda, Masanori Kugita, Kanako Kumamoto, Yuki Akari, Yuki Higashimoto, Shizuko Nagao, Takayuki Murata, Tetsushi Yoshikawa, Koki Taniguchi, Satoshi Komoto
  • Journal: Viruses
  • Year: 2024
Andrographolide, isolated from Andrographis paniculata, induces apoptosis in monocytic leukemia and multiple myeloma cells via augmentation of reactive oxygen species production
  • Authors: Doi H, Matsui T, Dijkstra JM, Ogasawara A, Higashimoto Y, Imamura S, Ohye T, Takematsu H, Katsuda I, Akiyama H
  • Journal: F1000Research
  • Year: 2021
Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection
  • Authors: Inaba M, Higashimoto Y, Toyama Y, Horiguchi T, Hibino M, Iwata M, Imaizumi K, Doi Y
  • Journal: International Journal of Infectious Diseases
  • Year: 2021
Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study
  • Authors: Kawamura Y, Hattori F, Higashimoto Y, Kozawa K, Yoshikawa T
  • Journal: Vaccine
  • Year: 2021
Dry loop–mediated isothermal amplification assay for detection of SARS-CoV-2 from clinical specimens
  • Authors: Higashimoto Y, Ihira M, Kawamura Y, Inaba M, Shirato K, Suzuki T, Hasegawa H, Kageyama T, Doi Y, Hata T et al.
  • Journal: Preprint
  • Year: 2020